Form 4: Bioventus Inc. Executive Sells Shares to Cover Taxes After Vesting

Katrina J. Church, SVP & Chief Compliance Officer at Bioventus Inc., sold 2,535 shares of Class A Common Stock to cover taxes after restricted stock units vested.

Summary

• Katrina J. Church, a Senior Vice President and Chief Compliance Officer at Bioventus Inc., sold 2,535 shares of Class A Common Stock on December 23, 2024.
• The sale was executed to cover taxes associated with the vesting of restricted stock units on December 20, 2024.
• The shares were sold at a weighted average price of $10.53, with individual transaction prices ranging from $10.41 to $10.71.
• The sale was conducted under a pre-arranged 10b5-1 trading plan adopted on June 20, 2023.
• Following the transaction, Ms. Church beneficially owns 47,264 shares of Bioventus Inc. Class A Common Stock.

Sentiment

Score: 5

Explanation: This is a routine transaction related to executive compensation and does not indicate any positive or negative sentiment about the company's performance.

Industry Context

This is a routine transaction for executives who receive stock-based compensation. The use of a 10b5-1 plan indicates a pre-planned approach to selling shares, which is common practice to avoid accusations of insider trading.

Comparison to Industry Standards

• The use of a 10b5-1 trading plan is a standard practice among publicly traded companies to allow insiders to sell shares without the risk of insider trading allegations.
• The sale of shares to cover taxes upon vesting of restricted stock units is a common occurrence for executives in publicly traded companies.
• Similar transactions are regularly reported by executives at companies like Medtronic, Stryker, and Zimmer Biomet, which are also in the medical device industry.

Stakeholder Impact

• The sale of shares by an executive may have a minor impact on the stock price, but it is unlikely to be significant given the relatively small number of shares sold and the pre-planned nature of the transaction.

Key Dates

Keywords

Bioventus Inc., insider trading, stock sale, Form 4, Katrina J. Church, 10b5-1 plan, executive compensation, restricted stock units